Clinical trial
Randomized,Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder
NCT02273154 is registered in ClinicalTrials.gov with Si Tianmei as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized,Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder
- Lead sponsor
- Si Tianmei
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2014
- Completion date
- December 31, 2015
- Enrollment
- 240 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
major depression disorder